Mindstrong Health Stock
Mindstrong Health is transforming the diagnosis and treatment of behavioral health disorders through the ubiquity of mobile technology
About Mindstrong Health Stock
Mindstrong's patented science and technology was developed by Dr. Dagum, and is based on four years of extensive clinical studies applying machine intelligence to human-computer interactions patterns. Dr. Dagum's work creates, for the first time, a way to objectively and continuously measure brain function day-to-day providing new insight not previously possible with traditional neuropsychological and imaging techniques. Mindstrong products are in clinical trials in numerous partnership projects with payers, providers, academics and the pharmaceutical industry to bring these new tools to bear on answering the most fundamental questions in behavioral health.
Investors
ARCH Venture Partners
Codiak Biosciences, Metacrine, Beam Therapeutics, Mindstrong Health
Funding History
| June 2017 | $14.0M |
|---|
Management
Co-Founder and Executive Chairman
Richard Klausner
Founder and CEO
Paul Dagum
Co-Founder and President
Thomas Insel
Press
Mindstrong Health hires leadership team with all-star tech product experience
TechCrunch - Dec, 9 2019
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Mindstrong Health or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
